Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has received an average rating of “Hold” from the twenty-one brokerages that are presently covering the company, MarketBeat.com reports. Fourteen investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $12.08.

Several brokerages recently commented on TDOC. DA Davidson dropped their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Piper Sandler decreased their target price on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a research report on Tuesday, August 6th. The Goldman Sachs Group initiated coverage on Teladoc Health in a research report on Friday. They issued a “buy” rating and a $14.00 target price for the company. TD Cowen cut their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st.

Teladoc Health Stock Up 2.8 %

TDOC opened at $9.21 on Wednesday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.59 billion, a P/E ratio of -1.60 and a beta of 0.90. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.54. The business’s fifty day simple moving average is $8.89 and its 200 day simple moving average is $9.36.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. As a group, equities research analysts anticipate that Teladoc Health will post -1.17 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, COO Michael Willem Waters sold 4,218 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now directly owns 78,309 shares in the company, valued at approximately $560,692.44. The trade was a 5.11 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Thomas Mckinley purchased 4,000 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 11.40 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 20,051 shares of company stock valued at $143,565. 0.95% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Teladoc Health by 2.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock valued at $641,000 after purchasing an additional 1,352 shares during the period. Covestor Ltd increased its holdings in Teladoc Health by 58.1% in the first quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock valued at $57,000 after purchasing an additional 1,403 shares during the period. Signaturefd LLC increased its holdings in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,715 shares during the period. Swiss National Bank increased its holdings in Teladoc Health by 0.6% in the first quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock valued at $4,936,000 after purchasing an additional 1,800 shares during the period. Finally, Blue Trust Inc. increased its holdings in Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.